CCR4 is a prognostic biomarker and correlated with immune infiltrates in head and neck squamous cell carcinoma.

Zhang, Yijian; Chen, Kai; Li, Li; Mao, Weidong; Shen, Dong; Yao, Ninghua; Zhang, Lei

Zhang, Yijian; Chen, Kai; Li, Li; Mao, Weidong; Shen, Dong; Yao, Ninghua; Zhang, Lei.

Afiliação

Zhang Y; Department of Otolaryngology-Head and Neck Surgery, Affiliated Hospital of Jiangnan University, Wuxi, China.
Chen K; Department of Radiotherapy, First People's Hospital of Yancheng, Yancheng, China.
Li L; Department of Oncology, Huaian Hospital, Huai'an, China.
Mao W; Department of Oncology, Jiangyin People's Hospital, Wuxi, China.
Shen D; Department of Oncology, Jiangyin People's Hospital, Wuxi, China.
Yao N; Department of Oncology, Affiliated Hospital of Nantong University, Nantong, China.
Zhang L; Department of Otolaryngology-Head and Neck Surgery, Affiliated Hospital of Jiangnan University, Wuxi, China.

Ann Transl Med ; 9(18): 1443, 2021 Sep.

Article em En | MEDLINE | ID: mdl-34733995

Palavras-chave

CC chemokine receptor 4 (CCR4); biomarker; head and neck squamous cell carcinoma (HNSC); immune infiltrates

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Ann Transl Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google